Short-term immunotherapy: A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis

被引:58
|
作者
Zenner, HP
Baumgarten, C
Rasp, G
Fuchs, T
Kunkel, G
Hauswald, B
Ring, J
Effendy, I
Behrendt, W
Frosch, PJ
Przybilla, B
Brunner, FX
Merk, HF
Kapp, A
Schnitker, J
Wolf, H
机构
[1] SCHERAX ARZNEIMITTEL GMBH,D-22589 HAMBURG,GERMANY
[2] UNIV TUBINGEN,HNO KLIN,TUBINGEN,GERMANY
[3] FREE UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,ABT KLIN IMMUNOL & ASTHMAPOLIKLIN,D-1000 BERLIN,GERMANY
[4] MAXIMILIANS UNIV,KLINIKUM GROSSHADERN,HNO KLIN & POLIKLIN,MUNICH,GERMANY
[5] UNIV GOTTINGEN,HAUTKLIN,D-3400 GOTTINGEN,GERMANY
[6] MED ACAD CARL GUSTAV CARUS,HNO KLIN,DRESDEN,GERMANY
[7] TECH UNIV MUNICH,DERMATOL KLIN & POLIKLIN,D-8000 MUNICH,GERMANY
[8] KLINIKUM PHILIPPS UNIV,MED ZENTRUM HAUTKRANKHEITEN,MARBURG,GERMANY
[9] UNIV LEIPZIG,HNO KLIN,D-7010 LEIPZIG,GERMANY
[10] UNIV WITTEN HERDECKE,WITTEN,GERMANY
[11] STADT KLINIKEN,HAUTKLIN,DORTMUND,GERMANY
[12] UNIV MUNICH,DERMATOL KLIN & POLIKLIN,D-80539 MUNICH,GERMANY
[13] UNIV WURZBURG,HNO KLIN & POLIKLIN,WURZBURG,GERMANY
[14] RHEIN WESTFAL TH AACHEN,HAUTKLIN,D-5100 AACHEN,GERMANY
[15] HANNOVER MED SCH,DERMATOL KLIN & POLIKLIN,HANNOVER,GERMANY
[16] INST ANGEW STAT,BIELEFELD,GERMANY
关键词
short-term immunotherapy; specific immunotherapy; allergic rhinitis; grass pollen; rye pollen; skin prick rest; specific IgE; specific IgG4;
D O I
10.1016/S0091-6749(97)70190-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Short-term immunotherapy (STI) can be beneficial for patients who are noncompliant,vith long-term specific immunotherapy. Objective: The efficacy and tolerance of STI with seven pre-seasonal injections of molecular standardized allergens from grass and rye pollen has been investigated in a double-blind, placebo-controlled multicenter study with 87 patients at 12 German University hospitals. Methods: Symptoms of the eyes, nose, and bronchi and use of symptomatic drugs were documented daily in diaries by patients with allergic rhinitis to grass and/or rye pollen and without bronchial asthma. Patients were monitored by skin prick test titration and measurement of levels of specific IgE and IgG4. Results: The median nasal score for the 10 weeks with the strongest symptoms during the gross pollen season was significantly lower (p = 0.014) with 35.0 for STI (n = 41) versus 69.0 for placebo (n = 40); the overall symptom score was 54.0 for STI versus 97.5 for placebo (p = 0.020). Only STI-treated patients exposed to less than 40 pollen grains per cubic meter per week showed a significantly lower nasal symptom score of 39.0 versus 75.0 for placebo (p = 0.006); these patients also had fewer nasal symptoms and less use of topical nasal drugs (p < 0.001). The threshold dose in skin prick tests was significantly higher, being 9.06 histamine equivalent for skin prick test (HEP) for STI-treated patients who received the maximum dose (n = 22) versus 4.33 HEP for placebo (p = 0.005). Specific IgE levels were significantly higher, being 55.9 SU/ml for STI versus 393 SU/ml for placebo after seven injections (p = 0.006) and level of specific IgG4 was 5.36% for STI versus 1.28% for placebo (p < 0.001). No severe systemic reactions were observed. Conclusion: Sn with seven preseasonal injections with molecular standardized allergens is effective and well tolerated.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [31] DOUBLE-BLIND, PLACEBO-CONTROLLED IMMUNOTHERAPY WITH A HIGH-MOLECULAR-WEIGHT, FORMALINIZED ALLERGOID IN GRASS-POLLEN ALLERGY
    BOUSQUET, J
    FRANK, E
    SOUSSANA, M
    HEJJAOUI, A
    MAASCH, HJ
    MICHEL, FB
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1987, 82 (3-4): : 550 - 552
  • [32] A randomized, double-blind placebo-controlled study of intranasal standardized cinnamon bark extract for seasonal allergic rhinitis
    Steels, Eleanor
    Steels, Elizabeth
    Deshpande, Pallavi
    Thakurdesai, Prasad
    Dighe, Satish
    Collet, Trudi
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 47
  • [33] Immunologic Effects and Tolerability Profile of In-Season Initiation of a Standardized-Quality Grass Allergy Immunotherapy Tablet: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial in Adults with Grass Pollen Induced Rhinoconjunctivitis
    Reich, Kristian
    Gessner, Christian
    Kroker, Axel
    Schwab, Jan Alexander
    Pohl, Wolfgang
    Villesen, Hanne
    Wuestenberg, Eike
    Emminger, Waltraud
    CLINICAL THERAPEUTICS, 2011, 33 (07) : 828 - 840
  • [34] Randomized double-blind placebo-controlled crossover study of efficacy of pollen blocker cream for perennial allergic rhinitis
    Li, Yanqing
    Wang, Dehui
    Liu, Quan
    Liu, Juan
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2013, 27 (04) : 299 - 303
  • [35] Sublingual immunotherapy - Results from a multi-centre, randomised, double-blind, placebo-controlled,study with a standardised birch and grass/rye pollen extract
    Drachenberg, KJ
    Pfeiffer, P
    Urban, E
    ALLERGOLOGIE, 2001, 24 (11) : 525 - 534
  • [36] The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions
    Klimek, L
    Wolf, H
    Mewes, T
    Dormann, D
    Reske-Kunz, A
    Schnitker, J
    Mann, W
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : 47 - 53
  • [37] Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis
    Patel, P
    Philip, G
    Yang, W
    Call, R
    Horak, F
    LaForce, C
    Gilles, L
    Garrett, GC
    Dass, SB
    Knorr, BA
    Reiss, TF
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 95 (06) : 551 - 557
  • [38] Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: Randomized double-blind, placebo-controlled clinical trial
    Tamura, Manabu
    Shikina, Takashi
    Morihana, Tetsuo
    Hayama, Masaki
    Kajimoto, Osami
    Sakamoto, Akane
    Kajimoto, Yoshitaka
    Watanabe, Osamu
    Nonaka, Chiaki
    Shida, Kan
    Nanno, Masanobu
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 143 (01) : 75 - 82
  • [39] Efficacy and safety of intratonsillar immunotherapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial
    Zhang, Junyan
    Yang, Xiaobin
    Chen, Guangui
    Hu, Jintao
    He, Ying
    Ma, Jinxiang
    Ma, Zhaoen
    Chen, Huifang
    Huang, Yuyi
    Wu, Qiurong
    Liu, Yongping
    Yu, Lu
    Zhang, Hong
    Lai, He
    Zhang, Jianguo
    Zhai, Jinming
    Huang, Minqi
    Zou, Zehong
    Tao, Ailin
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (03) : 346 - 354.e1
  • [40] Nasal immunotherapy at constant dosage: A double blind, placebo-controlled study in grass-allergic rhinoconjunctivitis
    Pocobelli, D
    Del Bono, A
    Venuti, L
    Falagiani, P
    Venuti, A
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 2001, 11 (02): : 79 - 88